Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Funds development of an FDA-cleared or FDA-approved wound barrier combination prototype with antimicrobial and/or antifungal properties for battlefield wound infection prevention and treatment.
⚑ Prototype Other Transaction Authority (pOTA) award; not a traditional grant/contract. · Applicant restrictions are stated only as a federal contract solicitation; no further class restriction specified in the notice. · Final product must already have FDA approval or clearance.
Unit fits — one characterization, each unit's own rules
| Physical Sciences & Engineering (demo) | 50 partial | technical depth: substantial; funds other (capped) |
| IPPRA | 27 weak | peripheral portfolio topic: national_security_defense; social/behavioral work is none; funds other — not a research fit |
| Tom Love Innovation Hub | 25 weak | prototyping/demonstration stage; deep-tech content |
Description
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0002 only extends the proposal due date).
Eligibility
Applicant restrictions (federal contract). Set-aside: . Notice type: Solicitation. Organization: DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA) / DEFENSE HEALTH AGENCY.
Apply
Proposal brief SEE AN EXAMPLE →
A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.
Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →
Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.